UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000040737
Receipt No. R000046513
Scientific Title Inter-fractional margin using respiratory gated for the patients with prostate cancer
Date of disclosure of the study information 2020/06/13
Last modified on 2022/06/15 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Inter-fractional margin using respiratory gated for the patients with prostate cancer
Acronym Inter-fractional margin using respiratory gated for the patients with prostate cancer
Scientific Title Inter-fractional margin using respiratory gated for the patients with prostate cancer
Scientific Title:Acronym Inter-fractional margin using respiratory gated for the patients with prostate cancer
Region
Japan

Condition
Condition Prostate cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify the change of organ locations and dose distribution in each irradiation for the patients with prostate cancer treated with carbon ion radiotherapy
Basic objectives2 Others
Basic objectives -Others The comparison of the DVH parameter of rectum and bladder using the calcurated margine
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes inter-fractional margin of the prostate and seminal vesicle
Key secondary outcomes The comparison of the DVH parameter of rectum and bladder using the calcurated margine

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria The prostate cancer patients treated with 12 fractionated carbon ion radiotherapy
Key exclusion criteria The patients who rejected the informed concent
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Goro
Middle name
Last name Kasuya
Organization QST hospital
Division name Treatment department
Zip code 263-8555
Address 4-9-1 anagawa Inage-ku Chiba
TEL +81-43-206-3306
Email kasuya.goro@qst.go.jp

Public contact
Name of contact person
1st name Goro
Middle name
Last name Kasuya
Organization QST hospital
Division name Treatment department
Zip code 263-8555
Address 4-9-1 anagawa Inage-ku Chiba
TEL +81-43-206-3306
Homepage URL
Email kasuya.goro@qst.go.jp

Sponsor
Institute Ministry of Education
Institute
Department

Funding Source
Organization Ministry of Education
Organization
Division
Category of Funding Organization Government offices of other countries
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Institutes for Quantum and Radiological Science a nd Technology Certified Review Board
Address 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba
Tel 043-206-4706
Email helsinki@qst.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 05 Month 18 Day
Date of IRB
2020 Year 05 Month 29 Day
Anticipated trial start date
2020 Year 06 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The calucuration of inter-fractional margin and the DVH analyses

Management information
Registered date
2020 Year 06 Month 12 Day
Last modified on
2022 Year 06 Month 15 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046513